论文部分内容阅读
作者对17例经~(131)Ⅰ治疗的甲状腺功能亢进(甲亢)患者及37例经丙基硫氧嘧啶治疗的甲亢患者进行治疗前及治疗后血中促甲状腺免疫球蛋白(ThyroidStimulating Immunoglobulin,TSAb)测定。发现在(131)Ⅰ治疗后最初3周内 TSAb 水平减低,而7周后
The authors investigated the effect of ThyroidStimulating Immunoglobulin (TSAb) in 17 cases of 131I-treated patients with hyperthyroidism and 37 cases of hyperthyroidism treated with propylthiouracil before and after treatment ). TSAb levels were found to be reduced within the first 3 weeks after (131) I treatment and after 7 weeks